Novel oral anticoagulants are effective alternatives. Recent data suggest that rivaroxaban and apixaban, both factor Xa inhibitors, and dabigatran, a direct thrombin inhibitor, as initial ...
Outcome assessment was also blinded. There was one large phase III trial of the direct thrombin (factor IIa) inhibitor dabigatran. There were six phase II trials of factor Xa inhibitors, edoxaban, ...
From the Division of Cardiovascular Medicine, Section of Hematology Research, Mayo Clinic, Rochester, MN. More than 2.5 million Americans are chronically anticoagulated for indications including ...
Comparison of 2 Population Health Management Approaches to Increase Vitamin B12 Monitoring in Patients Taking Metformin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback